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The aim of this work was to elucidate the impact of polyethylene glycol (PEG)
polymeric coating on the in vitro and in vivo stealthiness of magnetic nanocarriers
loaded or not with the anticancer drug doxorubicin. The comparison was made
between aqueous suspensions of superparamagnetic iron oxide nanoparticles
(SPIONs) stabilized by either citrate ions (C-SPIONs) or PEG5000 (P-SPIONs), the
latter being loaded or not with doxorubicin via the formation of a DOX-Fe2+ complex
(DLP-SPIONs).After determination of their relevant physico-chemical properties
(size and surface charge), nanoparticle (NP) stealthiness was studied in vitro (ability
to activate the complement system and uptake by monocytes and macrophage-like
cells) and in vivo in mice (blood half-life; t1/2, and biodistribution in main clearance
organs). These aspects were quantitatively assessed by atomic absorption
spectrometry (AAS). Complement activation dramatically decreased for sterically
stabilized P-SPIONs and DLP-SPIONs in comparison with C-SPIONs stabilized by
charge repulsion. Monocyte and macrophage uptake was also largely reduced for
pegylated formulations loaded or not with doxorubicin. The t1/2 in blood for P-SPIONs
was estimated to be 76 ± 6 min, with an elimination mainly directed to liver and
spleen. Thanks to their small size (<80 nm) and a neutral hydrophilic polymer-
extended surface, P-SPIONs exhibit prolonged blood circulation and thus potentially
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